Ardalan E. Ahmad (@ardalan_uromd) 's Twitter Profile
Ardalan E. Ahmad

@ardalan_uromd

UroOncologist, Assist. Prof @UManitoba, Research Director@MPC, Consulting Editor @EUPlatinum, Associate Editor @BMCUrology, Membership Chair @FocalSociety.

ID: 2169330182

calendar_today02-11-2013 00:59:13

890 Tweet

714 Followers

786 Following

Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo

Bladder cancer care is ⬆️⬆️expensive these days 💸. Costs skyrocket from $200K+ for high-risk NMIBC cases to $100K PER tx in advanced dz .. what’s the solution here ? #BladderCancer European Urology Sarah P. Psutka MD MS Ashish M. Kamat, MD, MBBS sciencedirect.com/science/articl…

Bladder cancer care  is ⬆️⬆️expensive these days   💸. Costs skyrocket from $200K+ for high-risk NMIBC cases to $100K PER tx in advanced dz .. what’s the solution here ? #BladderCancer <a href="/EUplatinum/">European Urology</a> <a href="/spsutkaMD/">Sarah P. Psutka MD MS</a> <a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> sciencedirect.com/science/articl…
Dr. Art Rastinehad (@drrastinehad) 's Twitter Profile Photo

🎓 Fellowship Alert! Join our lab to work on cutting-edge #prostatecancer research, #FocalTherapy, & AI in urology and Int. Urology. Collaborate with top experts, gain hands-on skills, & drive innovation. Apply now: forms.gle/SwNXrUQBbooV19… #AI Focal Therapy Society Northwell Urology

Focal Therapy Society (@focalsociety) 's Twitter Profile Photo

Not to be missed at #AUA25 in Las Vegas. Kara Watts hosts a Roundtable "Women in Focal Therapy" featuring Prof Caroline Moore Caroline Moore. Come to connect collaborate share ideas and learn from the leaders of the field. #focaltherapy #womeninurology Focal One SWIU

Not to be missed at #AUA25 in Las Vegas. <a href="/KaraWattsMD/">Kara Watts</a> hosts a Roundtable "Women in Focal Therapy" featuring Prof Caroline Moore <a href="/mrsprostate/">Caroline Moore</a>. Come to connect collaborate share ideas and learn from the leaders of the field. #focaltherapy #womeninurology <a href="/FocalOneHIFU/">Focal One</a> <a href="/SWIUorg/">SWIU</a>
Badar M. Mian, MD (@badarmian1) 's Twitter Profile Photo

Sign up now! app.swapcard.com/event/2025-ann… 📢Interested in comprehensive review of prostate biopsy: Rationale for current templates? Mechanisms of complications? How to reduce the risks? Technical improvements? Urological Institute@AlbanyMed Amer. Urol. Assn. UroResidency #pcsm #ProstateCancer #aua25

Sign up now! 
app.swapcard.com/event/2025-ann…
📢Interested in comprehensive review of prostate biopsy:
Rationale for current templates?
Mechanisms of complications?
How to reduce the risks?
Technical improvements?
<a href="/AlbanyMedUro/">Urological Institute@AlbanyMed</a> <a href="/AmerUrological/">Amer. Urol. Assn.</a> <a href="/UroResidency/">UroResidency</a> 
#pcsm #ProstateCancer #aua25
𝙳𝚊𝚟𝚒𝚍 𝙲𝚊𝚗𝚎𝚜 (@canesdavid) 's Twitter Profile Photo

🚨🚨🚨 In honor of #AUA25 and because I can’t help myself when it comes to sharing productivity hacks — Made a rapid-fire video🎥 showing 11 ways you should be using AI right now. Real stuff I actually use every day. Hope it helps. Did I miss anything? Comment below!

🚨🚨🚨
In honor of #AUA25 and because I can’t help myself when it comes to sharing productivity hacks —

Made a rapid-fire video🎥 showing 11 ways you should be using AI right now.

Real stuff I actually use every day. Hope it helps.

Did I miss anything? Comment below!
Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo

BOND-003 Cohort C Update at #AUA25 ➡️ Intravesical Cretostimogene Grenadenorepvec for HR BCG-unresponsive NMIBC •75.5% overall CR rate •64.1% CR at 12 months, 58.3% CR at 24 months📉 •97.3% free from MIBC progression at 24 mo

BOND-003 Cohort C Update at #AUA25 ➡️
Intravesical Cretostimogene Grenadenorepvec for HR BCG-unresponsive NMIBC
•75.5% overall CR rate
•64.1% CR at 12 months, 58.3% CR at 24 months📉
•97.3% free from MIBC progression at 24 mo
Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo

TAR-200 in BCG-unresponsive NMIBC #AUA25 •82% CR rate at anytime •53% ≥12-mo durability CR •86.6% cystectomy-free at 12 mo If you compare to other available tx➡️➡️At 12 mo duration ‼️TAR-200 53% ≥12-mo DOR vs Adstiladrin 46%, Anktiva+BCG 58%

TAR-200 in BCG-unresponsive NMIBC #AUA25
•82% CR rate at anytime 
•53% ≥12-mo durability CR
•86.6% cystectomy-free at 12 mo
If you compare to other available tx➡️➡️At 12 mo duration 
‼️TAR-200 53% ≥12-mo DOR vs Adstiladrin 46%, Anktiva+BCG 58%
Nathan Perlis (@nptdot) 's Twitter Profile Photo

Hope to see all AUA attendees at our concert Sunday night in Las Vegas! Come see your favourite urology band 🎸 🎤 🎹

European Urology (@euplatinum) 's Twitter Profile Photo

Don't Miss Out – Free Access Until the End of April! To celebrate the 50th anniversary of European Urology, all current and past issues from the European Urology Family of Journals are free to access until April 30! Enjoy groundbreaking research, expert reviews, and key insights

Rachel S. Rubin, MD (@drrachelrubin) 's Twitter Profile Photo

Oh. My. God. Look. At. This. Data. 11 million women w recurrent uti. If using vaginal estrogen 73% less MORTALITY 51% less SEPSIS 22% less hospitalizations 📉 the graphs don’t lie Elise J.B. De, MD should get a Nobel prize for this work #AUA25 Ashley Winter MD || Urologist

Oh. My. God. Look. At. This. Data. 

11 million women w recurrent uti. 

If using vaginal estrogen 

73% less MORTALITY
51% less SEPSIS
22% less hospitalizations 

📉 the graphs don’t lie 

<a href="/Dr_Elise_De/">Elise J.B. De, MD</a> should get a Nobel prize for this work 

#AUA25 <a href="/AshleyGWinter/">Ashley Winter MD || Urologist</a>
Ardalan E. Ahmad (@ardalan_uromd) 's Twitter Profile Photo

Excellent review on Foley catheters! Covers indications, insertion techniques, maintenance. A must-read for physicians & nursing staff! Highly recommend!

Daniel E Spratt (@drspratticus) 's Twitter Profile Photo

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute